University of Michigan - School of Nursing
Ann Arbor, Michigan, 48109, United States
NCT Number: NCT01856231
The purpose of this preliminary study is to examine the effects of a program that includes two-months of structured lab-based training. The proposed study will examine the effects of a lifestyle physical activity intervention designed to increase PA in people with moderate and severe COPD. The intervention includes a combination of (a) structured laboratory-based exercises with a behavioral intervention, (b) structured home-based exercises and (c) lifestyle physical activities performed at home. The subjects will be followed for a total of 18 weeks.
Looking for future studies?
Notify Me55 year and older
All sexes
Interventional
Not applicable
Ann Arbor, Michigan, 48109, United States
People with chronic obstructive pulmonary disease (COPD) experience a gradual decline in physical activity (PA). Exercise training in a structured pulmonary rehabilitation program can generate substantial gains in functional capacity, but increases in functional capacity do not necessarily lead to improvements in daily PA. The proposed study will examine the effects of a lifestyle physical activity intervention designed to increase PA in people with moderate and severe COPD. The intervention includes a combination of (a) structured laboratory-based exercises with a self-efficacy enhancing intervention, (b) structured home-based exercises and (c) lifestyle physical activities performed at home. The intervention gradually transitions subjects from the structured laboratory-based exercises that focus on walking and circuit training to fully integrated lifestyle physical activities that integrate structured home-based exercises and lifestyle physical activities into daily life. The purpose of this preliminary study is to examine the effects of a program that includes two-months of structured lab-based training and subjects will be followed for a total of 18 weeks.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subjects will come into an exercise lab 2 days per week and perform 10-20 minutes of walking, 13 strength training exercises, stretching and a behavioral intervention including goal setting, etc.
Time frame: During initial visit (week 1), at 6 or 10 weeks (depending on group placement), and at week 18
Subjects wear two activity monitors for seven consecutive days (Actipal and Actigraph). The study will compare the subject's activity level at the three time points listed.
Time frame: During initial visit (week 1), at 6 or 10 weeks (depending on group placement), and at week 18
Subjects complete a 6 minute walk test measuring the total distance he/she can walk in 6 minutes at the three time points listed.
Time frame: During initial visit (week 1), at 6 or 10 weeks (depending on group placement), and at week 18
Subjects complete a performance test measuring balance, gait speed, and leg strength (using a chair stand test) at the three time points listed.
Time frame: During initial visit (week 1), at 6 or 10 weeks (depending on group placement), and at week 18
Subjects complete a questionnaire answering questions about their level of dyspnea in various daily activities at the three time points listed.
Time frame: During initial visit (week 1), at 6 or 10 weeks (depending on group placement), and at week 18
Subjects fill out a questionnaire of their perceived physical activity at the three time points listed.
University of Michigan
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05972239
Behavior, COPD
Tradate, Varese, Italy
View Trial DetailsNCT03794921
Behavior, COPD
Boston, Massachusetts, United States
View Trial DetailsNCT05825638
Behavior, COPD
Le Havre, Normandy, France
View Trial DetailsNCT04911764
Behavior, COPD
Limoges, France
View Trial Details